000 03481cam a2200589 i 4500
001 ocn857062556
003 OCoLC
005 20221128212357.0
006 m d
007 cr |||||||||||
008 130605s2013 nyu ob 001 0 eng
010 _a 2020687104
040 _aDLC
_beng
_erda
_cDLC
_dYDXCP
_dN$T
_dOCLCF
_dEBLCP
_dAU@
_dSTF
_dE7B
020 _a9781628083392
_q(ebook)
020 _a1628083395
020 _z9781628083095
_q(hardback)
035 _a622963
_b(N$T)
035 _a(OCoLC)857062556
072 7 _aHEA
_x039000
_2bisacsh
072 7 _aMED
_x014000
_2bisacsh
072 7 _aMED
_x022000
_2bisacsh
072 7 _aMED
_x112000
_2bisacsh
072 7 _aMED
_x045000
_2bisacsh
049 _aMAIN
100 1 _aA�hmad, Suhail.
245 1 0 _aTuberculosis and multidrug-resistant tuberculosis :
_bepidemiology, diagnosis, resistance mechanisms, treatment strategies and novel drugs
_c
_h[E-Book]
264 1 _a[Hauppauge] New York :
_bNova Biomedical,
_c[2013]
300 _a1 online resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
490 1 _aAllergies and infectious diseases
504 _aIncludes bibliographical references (pages 79-128) and index.
588 _aDescription based on print version record.
505 0 _aTUBERCULOSIS AND MULTIDRUG-RESISTANT TUBERCULOSIS ; TUBERCULOSIS AND MULTIDRUG-RESISTANT TUBERCULOSIS ; Library of Congress Cataloging-in-Publication Data ; Contents; Preface ; Chapter I Natural History of Tuberculosis ; Chapter II Global Epidemiology of TB, Drug-Resistant TB, MDR-TB and XDR-TB ; Chapter III Chemotherapy for TB and Evolution of Drug-Resistant TB ; Chapter IV Anti-TB Drugs: ChMechanism of Action and Molecular Basis of Resistance ; Chapter V Diagnosis of Active TB Disease ; Chapter VI Diagnosis of Drug-Resistant TB, MDR-TB and XDR-TB.
505 8 _a6A. Conventional Diagnosis of Drug-Resistant TB, MDR-TB and XDR-TB 6B. Molecular Diagnosis of Drug-Resistant TB, MDR-TB and XDR-TB ; Chapter VII Treatment of Drug-Resistant TB, MDR-TB and XDR-TB ; 7A. Treatment of Drug-Resistant TB, MDR-TB and XDR-TB in HIV-Seronegative Adults ; 7B. Treatment of Drug-Resistant TB in Children ; 7C. Treatment of Drug-Resistant TB in HIV-Coinfected Patients ; Chapter VIII New Drugs for the Treatment of TB and Drug-Resistant TB ; 8A. Clinical Re-evaluation of Existing Drugs ; 8B. New Anti-TB Drugs Under Development ; 8B.1. New Drugs under Clinical Evaluation.
505 8 _a8B.2. New Drugs in Preclinical Development 8B.3. Promising Lead Compounds as Anti-TB Drugs; Chapter IX Concluding Remarks ; References; Index.
590 _aMaster record variable field(s) change: 050, 082, 650
650 0 _aTuberculosis.
650 0 _aMultidrug-resistant tuberculosis.
650 0 _aMultidrug-resistant tuberculosis
_xChemotherapy.
650 0 _aAntitubercular agents.
_95248
700 1 _aMokaddas, Eiman.
830 0 _aAllergies and infectious diseases.
856 4 0 _uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=622963
_yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
938 _aYBP Library Services
_bYANK
_n11055473
938 _aEBSCOhost
_bEBSC
_n622963
938 _aebrary
_bEBRY
_nebr10740851
938 _aProQuest Ebook Central
_bEBLB
_nEBL3022921
942 _n0
994 _a92
_bN$T
999 _c91390
_d91390